A kind of lidocaine hydrochloride gel and preparation method thereof
By using polyglycerol oleate and sucrose ester as permeability promoters, the permeability and universality of lidocaine hydrochloride gels are improved, and the poor permeability and universality of lidocaine hydrochloride gels in the prior art are solved. Poor problems achieve better sedation and safety.
Patent Information
- Application Number
- CN202410215824.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-27
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-02-27
AI Technical Summary
The existing lidocaine hydrochloride gels have poor permeability and poor universality, which leads to poor analgesic effects and is prone to the risk of excessive drug absorption.
The ratio of lidocaine hydrochloride gel is adjusted by using polyglycerol oleate and sucrose esters as permeability agents, and the fluidity of the lipid bilayer is improved through the interaction between sucrose esters and keratinocytes and polyglycerol oleate. Promote the penetration of active ingredients.
The uniform permeability of lidocaine hydrochloride gel in patients with different dosing positions and mucosal characteristics is achieved, which improves the effectiveness and safety of sedation and avoids the risk of excessive drug absorption.
Smart Images

Figure BDA0004716494160000061 
Figure BDA0004716494160000071 
Figure BDA0004716494160000081
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of pharmaceutical preparations, and in particular to a lidocaine hydrochloride gel and a preparation method thereof. Background Art
[0002] Lidocaine hydrochloride gel is an amide local anesthetic transdermal preparation that stabilizes neuronal membranes by inhibiting the ion flux generated by impulse initiation and conduction, producing analgesic effects after transdermal administration.
[0003] In the existing lidocaine hydrochloride gel, azone, propylene glycol, urea, menthol / eucalyptus oil, etc. are mainly used as transdermal enhancers. However, the above transdermal enhancers have a low permeability to lidocaine hydrochloride and a poor analgesic effect. It is usually necessary to increase the single dose, but when the single dose is too large, there is a risk of blocking the lumen. In addition, when lidocaine hydrochloride gel is used for different administration sites or patients with different mucosal characteristics, the onset time and analgesic effect shown are also different. If used improperly, it is easy to cause the risk of excessive dosage, which causes secondary damage to the patient.
[0004] Therefore, there is a need to provide a lidocaine hydrochloride gel with good penetration effect and universal applicability to meet the use requirements of patients with different administration sites and different mucosal characteristics. Summary of the invention
[0005] In order to overcome the problems of poor permeability and poor universality of lidocaine hydrochloride gel in the prior art, the present application provides a lidocaine hydrochloride gel and a preparation method thereof.
[0006] In the first aspect, the lidocaine hydrochloride gel provided by the present application adopts the following technical solution:
[0007] A lidocaine hydrochloride gel comprises the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 0.7-10 parts of a penetration enhancer, 1.4-2.2 parts of a gel matrix, 1-1.5 parts of sodium hydroxide and 90-95 parts of water;
[0008] The penetration enhancers are polyglycerol oleate and sucrose ester.
[0009] The present application uses polyglycerol oleate and sucrose ester as penetration enhancers and adjusts the ratio of the components of lidocaine hydrochloride gel to prepare a lidocaine hydrochloride gel with a high active ingredient permeability. During use, the lidocaine hydrochloride gel will stimulate different penetration-enhancing effects according to different use sites, so that the lidocaine hydrochloride active ingredient shows similar permeability on the skin surface of patients at different administration sites or with different mucosal characteristics, thereby avoiding the problems of poor anesthetic effect or toxic reaction caused by excessive drug absorption in the existing lidocaine hydrochloride gel during clinical use.
[0010] In the present application, in the human epidermis, the stratum corneum inhibits the penetration of active ingredients, and the present application promotes the transfer of active ingredients on the cell membrane by adding sucrose esters and utilizing the interaction between sucrose esters and keratin fibers in keratinocytes; in the human dermis, the fluidity of the lipid bilayer is poor, and polyglycerol oleate can increase the fluidity of the lipid bilayer, improve the solubilization of lipids, and thus promote the transfer of active ingredients in the intercellular space. In addition, sucrose esters and polyglycerol oleate can also improve the thermodynamic activity of lidocaine hydrochloride and increase the permeability of lidocaine hydrochloride. Therefore, the lidocaine hydrochloride gel provided in the present application can stimulate different penetration-promoting mechanisms according to different parts of the human body, so as to meet the use requirements of patients with different administration locations and different mucosal characteristics.
[0011] In some embodiments, the weight portion of the coagulant may be 0.7-3 parts, 0.7-5 parts, 0.7-8 parts, 0.7-10 parts, 3-5 parts, 3-8 parts, 3-10 parts, 5-8 parts, 5-10 parts or 8-10 parts.
[0012] In a specific embodiment, the weight portion of the coagulant can also be 0.7 parts, 3 parts, 5 parts, 8 parts
[0013] Or 10 servings.
[0014] Optionally, the lidocaine hydrochloride gel comprises the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 3-8 parts of a permeation enhancer, 1.4-2.2 parts of a gel matrix, 1-1.5 parts of sodium hydroxide and 90-95 parts of water.
[0015] Optionally, the weight ratio of the polyglycerol oleate to sucrose ester is 1:(0.5-1.3).
[0016] In some embodiments, the weight ratio of polyglycerol oleate to sucrose ester can be 1:(0.5-0.7), 1:(0.5-0.9), 1:(0.5-1.1), 1:(0.5-1.3), 1:(0.7-0.9), 1:(0.7-1.1), 1:(0.7-1.3), 1:(0.9-1.1), 1:(0.9-1.3) or 1:(1.1-1.3).
[0017] In a specific embodiment, the weight ratio of the polyglycerol oleate to the sucrose ester can also be 1:0.5, 1:0.7, 1:0.9, 1:1.1 or 1:1.3.
[0018] Optionally, the weight ratio of the polyglycerol oleate to sucrose ester is 1:(0.7-1.1).
[0019] In the present application, the weight ratio of polyglycerol oleate and sucrose ester will affect the permeability of the active ingredient in the lidocaine hydrochloride gel. Through experimental research, it was found that the present application further controls the weight ratio of polyglycerol oleate and sucrose ester within the above range, and the obtained lidocaine hydrochloride gel has better permeability and a faster onset of sedative effect.
[0020] Optionally, the gel matrix is selected from one or more of hydroxypropyl methylcellulose, sodium hydroxymethylcellulose, gelatin and starch.
[0021] Optionally, the lidocaine hydrochloride gel further comprises 0.3-1 parts of an antibacterial agent, and the antibacterial agent is selected from methylparaben and propylparaben.
[0022] In a second aspect, the present application provides a method for preparing lidocaine hydrochloride gel.
[0023] A method for preparing lidocaine hydrochloride gel comprises the following steps:
[0024] (1) First, dissolve the penetration enhancer and sodium hydroxide in water and mix well;
[0025] (2) then adding the gel matrix and stirring evenly;
[0026] (3) Finally, lidocaine hydrochloride is added thereto and stirred thoroughly to obtain lidocaine hydrochloride gel.
[0027] Optionally, the stirring speed in step (3) is 500-700 r / min, and the stirring time is 20-30 min.
[0028] In the present application, the stirring speed and time in step (3) will affect the permeability of lidocaine, an active ingredient in lidocaine hydrochloride gel. Experimental investigations have found that by controlling the stirring speed and stirring time in step (3) within the above range, the active ingredient lidocaine in the obtained lidocaine hydrochloride gel has better permeability on the skin surface and takes effect faster.
[0029] In some embodiments, the stirring speed may be 400-500 r / min, 400-600 r / min, 400-700 r / min, 500-600 r / min, 500-700 r / min or 600-700 r / min.
[0030] In a specific embodiment, the stirring speed can also be 400 r / min, 500 r / min, 600 r / min or 700 r / min.
[0031] In some embodiments, the stirring time may be 15-20 min or 20-30 / min.
[0032] In a specific embodiment, the stirring time can also be 15 min, 20 min or 30 / min.
[0033] In summary, this application has the following beneficial effects:
[0034] 1. The present application uses polyglycerol oleate and sucrose ester as penetration enhancers to prepare a lidocaine hydrochloride gel, which has excellent active ingredient permeability on the skin surface; and the lidocaine hydrochloride gel can stimulate different penetration enhancement mechanisms according to different parts of the human body, thereby meeting the use requirements of patients with different administration sites and different mucosal characteristics.
[0035] 2. This application controls the amount of penetration enhancer added within the range of 3-8 parts, which can ensure a better penetration enhancement effect based on a smaller amount of penetration enhancer, and the 24h cumulative absorption rate can reach more than 60%.
[0036] 3. The present application further controls the weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer within the range of 1: (0.7-1.1), and the obtained lidocaine hydrochloride gel has better permeability and a faster onset of sedative effect.
[0037] 4. In the preparation method of lidocaine hydrochloride gel provided in the present application, by controlling the stirring speed of step (3) within the range of 500-700 r / min and the stirring time within the range of 20-30 min, the active ingredient lidocaine in the obtained lidocaine hydrochloride gel has better active ingredient permeability on the skin surface and takes effect faster, and its 2h cumulative absorption rate is 7.46-7.84%, and the 24h cumulative absorption rate is 60.24-62.14%. DETAILED DESCRIPTION
[0038] The present application provides a lidocaine hydrochloride gel, comprising the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 0.7-10 parts of a penetration enhancer, 1.4-2.2 parts of a gel base, 1-1.5 parts of sodium hydroxide, 0.3-1 parts of an antibacterial agent, and 90-95 parts of water; further, the lidocaine hydrochloride gel comprises the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 3-8 parts of a penetration enhancer, 1.4-2.2 parts of a gel base, 1-1.5 parts of sodium hydroxide, and 90-95 parts of water.
[0039] Wherein, the penetration enhancer is polyglycerol oleate and sucrose ester, and the weight ratio of polyglycerol oleate and sucrose ester is 1:(0.5-1.3); further, the weight ratio of polyglycerol oleate and sucrose ester is 1:(0.7-1.1).
[0040] The preparation method of the above lidocaine hydrochloride gel comprises the following steps:
[0041] (1) First, dissolve the penetration enhancer and sodium hydroxide in water and mix well;
[0042] (2) then adding the gel matrix and stirring evenly;
[0043] (3) Finally, lidocaine hydrochloride is added thereto, and stirred at a stirring speed of 500-700 r / min for 20-30 min to obtain lidocaine hydrochloride gel.
[0044] In the present application, lidocaine hydrochloride is the raw material drug, with batch number Y202301003, purchased from Shanxi Shuangyan Pharmaceutical Co., Ltd.; polyglycerol oleate was purchased from Gattefossé (Shanghai) Trading Co., Ltd.; sucrose ester was purchased from Guangzhou Huili Chemical Co., Ltd. with batch number 7821X111; the gel matrix is hydroxypropyl methylcellulose, purchased from Ashland Chemical (Nanjing) Co., Ltd. with batch number NPH-0053; the raw materials, reagents, solvents, etc. of the present application can all be obtained commercially.
[0045] The present application is further described in detail below in combination with embodiments, comparative examples and performance testing experiments.
[0046] Examples 1-5
[0047] Examples 1-5 each provide a lidocaine hydrochloride gel.
[0048] The difference between the above embodiments is that the amount of the permeation enhancer added to the lidocaine hydrochloride gel is specifically shown in Table 1 below.
[0049] The preparation method of lidocaine hydrochloride gel provided in Examples 1-5 comprises the following steps:
[0050] (1) First, a penetration enhancer, 0.5 g of propylparaben and 1.5 g of sodium hydroxide are dissolved in 90 g of water and mixed evenly; wherein the penetration enhancer is polyglycerol oleate and sucrose ester in a weight ratio of 1:0.9.
[0051] (2) Then add 2 g of gel matrix and stir evenly;
[0052] (3) Finally, 2 g of lidocaine hydrochloride was added thereto, and the mixture was stirred at a stirring speed of 600 r / min for 30 min to obtain lidocaine hydrochloride gel.
[0053] Table 1 Addition amount of penetration enhancer in lidocaine hydrochloride gel provided in Examples 1-5
[0054] Example Amount of penetration enhancer added (g) 1 0.7 2 3 3 5 4 8 5 10
[0055] Embodiment 6-9
[0056] Examples 6-9 each provide a lidocaine hydrochloride gel.
[0057] The difference between the above embodiment and embodiment 3 is that the weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer is specifically shown in Table 2 below.
[0058] Table 2 Weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer of Example 3, Example 6-9
[0059] Example Weight ratio of polyglycerol oleate and sucrose ester 3 1:0.9 6 1:0.5 7 1:0.7 8 1:1.1 9 1:1.3
[0060] Examples 10-13
[0061] Examples 10-13 each provide a lidocaine hydrochloride gel.
[0062] The difference between the above-mentioned embodiment and embodiment 3 is that in the preparation method of lidocaine hydrochloride gel, the stirring speed and stirring time of step (3) are specifically shown in Table 3 below.
[0063] Table 3 Stirring speed and stirring time in the preparation methods of Example 3 and Examples 10-13
[0064] Example Stirring speed (r / min) Stirring time (min) 3 600 30 10 500 30 11 700 20 12 400 30 13 600 15
[0065] Comparative Example 1
[0066] Comparative Example 1 provides a lidocaine hydrochloride gel.
[0067] The difference between the comparative example and Example 3 is that the penetration enhancer is polyglycerol oleate.
[0068] Comparative Example 2
[0069] Comparative Example 2 provides a lidocaine hydrochloride gel.
[0070] The difference between the comparative example and Example 3 is that the penetration enhancer is sucrose ester.
[0071] Comparative Example 3
[0072] Comparative Example 3 provides a lidocaine hydrochloride gel.
[0073] The difference between the comparative example and Example 3 is that the added amount of the penetration enhancer is 0.
[0074] Comparative Example 4
[0075] Comparative Example 4 provides a lidocaine hydrochloride gel.
[0076] The above-mentioned lidocaine hydrochloride gel includes 2g of lidocaine hydrochloride, and the gel matrix is 2g of xanthan gum, 2g of hydroxypropyl methylcellulose E4M, 0.1g of 0.1M sodium hydroxide, 80g of water for injection, 1g of vitamin P, 2g of eucalyptus oil, 5g of Span 65, 10g of Tween 80, and 4g of polyethylene glycol 400.
[0077] The preparation method of lidocaine hydrochloride gel of comparative example 4 comprises the following steps:
[0078] (1) Extracting eucalyptus oil;
[0079] (2) mixing the eucalyptus oil extracted in step (1) with Span 65, Tween 80 and polyethylene glycol 400;
[0080] (3) dissolving an appropriate amount of vitamin P in water for injection to obtain a vitamin P aqueous solution; then weighing an appropriate amount of gel matrix and adding the vitamin P aqueous solution to dissolve, and finally adding 0.1 M sodium hydroxide and adjusting the pH value to 6.2 to obtain a gel matrix solution;
[0081] (4) Weighing a prescribed amount of lidocaine hydrochloride, adding it to the gel matrix solution of step (3), stirring thoroughly, and filtering;
[0082] (5) The product of step (2) and the product of step (4) are uniformly mixed to obtain lidocaine hydrochloride gel.
[0083] Performance testing
[0084] The performance of the lidocaine hydrochloride gel provided in Examples 1-13 and Comparative Examples 1-4 was tested, and the results are shown in Table 4 below.
[0085] (I) In vitro transdermal test method: refer to "New Dosage Forms and New Technologies of Drugs" edited by Lu Bin: New Dosage Forms for Transdermal Administration. The modified Franz diffusion cell method was used, with the abdominal skin of 3-month-old rats as a barrier, and the lidocaine hydrochloride gel provided in Examples 1-13 and Comparative Examples 1-5 was used to conduct an in vitro transdermal test. The specific experimental method is:
[0086] (1) Fifty-one healthy rats aged 3 months were divided into 17 groups, with 3 rats in each group.
[0087] (2) After the mice were anesthetized and killed, the abdominal hair was removed with scissors, the undamaged skin was removed, the subcutaneous tissue was removed, and the skin was washed and fixed to the release port of the Franz diffusion cell. A pH 7.4 phosphate buffer was added to the receiving chamber as the release medium to keep the endothelial layer in close contact with the solution. The lidocaine hydrochloride gel was applied to the skin, and the water bath was adjusted to keep the temperature of the outer layer constant at (37±0.5)°C. The stirring speed was 300 rpm. 2 ml of the release medium was absorbed at 2h, 4h, 6h, 8h, 10h, 12h, 16h, and 24h, and an equal amount of PBS solution was added at the same time. The amount of lidocaine in the mouse skin release medium was detected, and the cumulative absorption rate was calculated, taking the average value of 3 mice in each group. The calculation formula for the cumulative absorption rate is as follows:
[0088] Cumulative absorption rate = amount of lidocaine in the release medium / total amount of lidocaine in lidocaine hydrochloride gel × 100%
[0089] Table 4 In vitro skin permeation test results obtained in Examples 1-13 and Comparative Examples 1-4
[0090]
[0091]
[0092] According to the test results in Table 4, the lidocaine hydrochloride gel provided by Examples 1-13 of the present application has a high permeability on the skin surface, and its 2h cumulative absorption rate is greater than 7%, and the 24h cumulative absorption rate is greater than 50%; while the 2h cumulative absorption rate of lidocaine hydrochloride on the skin surface in the related art provided by Comparative Example 4 is only 4.56%, and the 24h cumulative absorption rate is 26.96%. Therefore, it is shown that the lidocaine hydrochloride gel provided by the present application has a good permeability effect on the skin surface and a fast onset of action. When it is used for patients, a sedative effect can be quickly achieved with a small amount of use, thereby avoiding the risk of excessive dosage or clogging of the lumen.
[0093] The test results of Examples 1-5 and Comparative Examples 1-3 show that in Comparative Example 1, polyglycerol oleate is used as a penetration enhancer, and the 2h cumulative absorption rate of the active ingredient lidocaine in the lidocaine hydrochloride gel prepared is only 6.04%, and the 24h cumulative absorption rate is only 44.58%; in Comparative Example 2, sucrose ester is used as a penetration enhancer, and the 2h cumulative absorption rate of the active ingredient lidocaine in the lidocaine hydrochloride gel prepared is only 5.83%, and the 24h cumulative absorption rate is only 42. .88%; the active ingredient lidocaine in the lidocaine hydrochloride gel prepared without adding a penetration enhancer in comparative example 3 has a 2h cumulative absorption rate on the skin surface of only 2.13%, and a 24h cumulative absorption rate of only 32.66%; while the active ingredient lidocaine in the lidocaine hydrochloride gel prepared in Examples 1-5 using polyglycerol oleate and sucrose ester as penetration enhancers has a 2h cumulative absorption rate of 7.21-7.88% on the skin surface, and a 24h cumulative absorption rate of 56.92-62.28%. Therefore, it is explained that the lidocaine hydrochloride gel obtained in the present application has a fast onset of efficacy and a high penetration rate of the active ingredient by using polyglycerol oleate and sucrose ester as penetration enhancers and controlling the addition amount of the penetration enhancer within the range of 0.7-10 parts.
[0094] Further comparison with Examples 1-5 revealed that Example 2-4 controls the amount of permeation enhancer added within the range of 3-8 parts, which can ensure a better permeation enhancement effect based on a smaller amount of permeation enhancer, and the 24h cumulative absorption rate can reach more than 60%.
[0095] The test results of Example 3 and Examples 6-9 show that, with the change of the weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer, the cumulative absorption rate of lidocaine, the active ingredient in the lidocaine hydrochloride gel, on the skin surface shows a trend of first increasing and then decreasing, wherein the initial absorption rate and cumulative absorption rate of Example 3 and Examples 7-8 are significantly better than those of Example 6 and Example 9. Therefore, it is explained that the present application further controls the weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer within the range of 1: (0.7-1.1), and the lidocaine hydrochloride gel obtained has better permeability and faster sedative effect.
[0096] The test results of Examples 3 and 10-13 show that in Examples 3 and 10-11, the stirring speed and stirring time of step (3) are controlled within the following ranges: the stirring speed is 500-700 r / min, the time is 20-30 min, and the 2h cumulative absorption rate of the active ingredient lidocaine in the obtained lidocaine hydrochloride gel on the skin surface is 7.46-7.84%, and the 24h cumulative absorption rate is 60.24-62.14%; in Example 12, the stirring speed of step (3) is controlled within the following ranges: the stirring speed is 500-700 r / min, the time is 20-30 min, and the active ingredient lidocaine in the lidocaine hydrochloride gel is obtained. The stirring speed of step (3) is controlled to 400r / min, and the time is controlled to 30min. The 2h cumulative absorption rate of lidocaine, the active ingredient, on the skin surface in the obtained lidocaine hydrochloride gel is 7.17%, and the 24h cumulative absorption rate is 54.86%; Example 13 The stirring speed of step (3) is controlled to 600r / min, and the time is controlled to 15min. The 2h cumulative absorption rate of lidocaine, the active ingredient, on the skin surface in the obtained lidocaine hydrochloride gel is 7.06%, and the 24h cumulative absorption rate is 54.18%. Therefore, it is explained that the present application controls the stirring speed of step (3) within the range of 500-700r / min, and the stirring time is controlled within the range of 20-30min, and the active ingredient permeability of the obtained lidocaine hydrochloride gel is better.
[0097] In summary, the present application provides a lidocaine hydrochloride gel prepared by using polyglycerol oleate and sucrose ester as penetration enhancers, and the obtained lidocaine hydrochloride gel has a fast onset of efficacy and a high permeability of active ingredients by controlling the weight of the penetration enhancer within the range of 0.7-10 parts. By further controlling the weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer within the range of 1: (0.7-1.1), the obtained lidocaine hydrochloride gel has better permeability and a faster onset of sedative effect.
[0098] (II) Comparative test of penetration effect in different skin parts Test method: Select pig skin from different parts, including abdominal skin, back skin, ear epidermis and uterine mucosa, and then apply lidocaine hydrochloride gel on the surface of the above skin respectively. Refer to (I) in vitro permeation test to detect the amount of lidocaine in each skin release medium and calculate the cumulative absorption rate.
[0099] The penetration effects of lidocaine hydrochloride gels of Examples 1-13 and Comparative Examples 1-4 on different skin sites were tested in turn according to the above method. The results are shown in Table 5 below.
[0100] Table 5 Skin penetration effects of lidocaine hydrochloride gel in different parts of examples 1-13 and comparative examples 1-4
[0101]
[0102]
[0103]
[0104]
[0105] The test results of comparative examples 1-4 show that the 24h cumulative absorption rate of lidocaine, an active ingredient, in the lidocaine hydrochloride gel prepared by using polyglycerol oleate as a penetration enhancer on different skin surfaces is 14.50-20.41%; the 24h cumulative absorption rate of lidocaine, an active ingredient, in the lidocaine hydrochloride gel prepared by using sucrose ester as a penetration enhancer on different skin surfaces is 14.11-17.18%; the 24h cumulative absorption rate of lidocaine, an active ingredient, in the lidocaine hydrochloride gel prepared by using no penetration enhancer in comparative example 3 is 11.31-15.87%; the 24h cumulative absorption rate of lidocaine, an active ingredient, in the lidocaine hydrochloride gel in the related art provided by comparative example 4 is 13.49-18.91% on different skin surfaces. All of them have poor penetration effects, and the penetration effects on different skin surfaces vary greatly.
[0106] The test results of Examples 1 to 5 show that the 24h cumulative absorption rate of the active ingredient lidocaine in the lidocaine hydrochloride gel prepared with polyglycerol oleate and sucrose ester as penetration enhancers on different skin surfaces is 16.02-35.35%, and the absorption rate of the skin in different parts is significantly improved.
[0107] It can be seen from the test results of Example 3 and Examples 6-9 that as the proportion of sucrose ester in the penetration enhancer increases, the difference in absorption rate of different parts of pig skin gradually decreases.
[0108] Therefore, it is explained that the present application uses polyglycerol oleate and sucrose ester as penetration enhancers, and controls the addition amount of the penetration enhancers within the range of 0.7-10 parts, and the obtained lidocaine hydrochloride gel has a fast onset of efficacy and a high permeability of the active ingredient. The weight ratio of polyglycerol oleate and sucrose ester in the penetration enhancer is controlled within the range of 1: (0.7-1.1), so that the lidocaine hydrochloride gel can show similar permeability on the skin surface of patients with different administration sites or different mucosal characteristics.
[0109] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. A lidocaine hydrochloride gel, It is characterized in that The invention comprises the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 0.7-10 parts of a penetration enhancer, 1.4-2.2 parts of a gel matrix, 1-1.5 parts of sodium hydroxide and 90-95 parts of water; The penetration enhancer is polyglycerol oleate and sucrose ester; the weight ratio of polyglycerol oleate to sucrose ester is 1:(0.7-1.1).
2. The lidocaine hydrochloride gel according to claim 1, It is characterized in that The lidocaine hydrochloride gel comprises the following components in parts by weight: 1.5-2.5 parts of lidocaine hydrochloride, 3-8 parts of a permeation enhancer, 1.4-2.2 parts of a gel matrix, 1-1.5 parts of sodium hydroxide and 90-95 parts of water.
3. The lidocaine hydrochloride gel according to claim 1, It is characterized in that The gel matrix is selected from one or more of hydroxypropyl methylcellulose, sodium hydroxymethylcellulose, gelatin and starch.
4. The lidocaine hydrochloride gel according to any one of claims 1 to 3, It is characterized in that The lidocaine hydrochloride gel further comprises 0.3-1 parts of an antibacterial agent, and the antibacterial agent is selected from methylparaben and propylparaben.
5. A method for preparing lidocaine hydrochloride gel as claimed in any one of claims 1 to 4, It is characterized in that The following steps are involved: (1) First, dissolve the penetration enhancer and sodium hydroxide in water and mix well; (2) Then add the gel matrix and stir evenly; (3) Finally, add lidocaine hydrochloride and stir well to obtain lidocaine hydrochloride gel.
6. The method for preparing lidocaine hydrochloride gel according to claim 5, It is characterized in that The stirring speed in step (3) is 500-700 r / min, and the stirring time is 20-30 min.
